Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
WASHINGTON (Nexstar) — A U.S. Food and Drug Administration panel on Friday rejected Pfizer’s request to administer a third COVID-19 booster shot to the general public. The independent advisory ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results